IN2014MU00205A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MU00205A IN2014MU00205A IN205MU2014A IN2014MU00205A IN 2014MU00205 A IN2014MU00205 A IN 2014MU00205A IN 205MU2014 A IN205MU2014 A IN 205MU2014A IN 2014MU00205 A IN2014MU00205 A IN 2014MU00205A
- Authority
- IN
- India
- Prior art keywords
- relates
- mesalamine
- suppositories
- compositions
- pharmaceutical
- Prior art date
Links
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical group NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 abstract 3
- 229960004963 mesalazine Drugs 0.000 abstract 3
- 239000000829 suppository Substances 0.000 abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 206010009900 Colitis ulcerative Diseases 0.000 abstract 1
- 206010036774 Proctitis Diseases 0.000 abstract 1
- 206010036783 Proctitis ulcerative Diseases 0.000 abstract 1
- 201000006704 Ulcerative Colitis Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN205MU2014 IN2014MU00205A (enExample) | 2014-01-21 | 2014-01-21 | |
| US14/600,373 US20150202149A1 (en) | 2014-01-21 | 2015-01-20 | Pharmaceutical compositions of mesalamine suppositories |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN205MU2014 IN2014MU00205A (enExample) | 2014-01-21 | 2014-01-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MU00205A true IN2014MU00205A (enExample) | 2015-08-28 |
Family
ID=53543846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN205MU2014 IN2014MU00205A (enExample) | 2014-01-21 | 2014-01-21 |
Country Status (2)
| Country | Link |
|---|---|
| US (1) | US20150202149A1 (enExample) |
| IN (1) | IN2014MU00205A (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8217083B2 (en) * | 2007-06-08 | 2012-07-10 | Aptalis Pharma Canada Inc. | Mesalamine suppository |
-
2014
- 2014-01-21 IN IN205MU2014 patent/IN2014MU00205A/en unknown
-
2015
- 2015-01-20 US US14/600,373 patent/US20150202149A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20150202149A1 (en) | 2015-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022009148A (es) | Composiciones y metodos para el tratamiento de hemoglobinopatias. | |
| MX2019003623A (es) | Composiciones y metodos para el tratamiento de afecciones oftalmicas. | |
| IL247923B (en) | 4-substituted nucleotide derivatives as HIV reverse transcriptase inhibitors | |
| EP3960735C0 (en) | QUINAZOLINE DERIVATIVES USED TO TREAT HIV | |
| MX2020005213A (es) | Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos. | |
| PH12016502586A1 (en) | Lipid comprising docosapentaenoic acid | |
| EP3174874A4 (en) | BERBERINSALZE, URSODEOXYCHOLSALZE AND COMBINATIONS, METHOD FOR THE PRODUCTION AND THE APPLICATION THEREOF | |
| EA201691582A1 (ru) | Новые фармацевтические препараты | |
| ZA201707303B (en) | Compositions and methods for the treatment of immunodeficiency | |
| PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| PH12018500659A1 (en) | Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof | |
| GB201400442D0 (en) | Compositions for use in the treatment of ulcerative colitis | |
| MX2017004808A (es) | Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple. | |
| MX370628B (es) | Composiciones y metodos para tratar las espinillas. | |
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| PH12017501022B1 (en) | Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same | |
| SG10201900598TA (en) | Factor viii formulation | |
| IN2014MU00916A (enExample) | ||
| IN2014CH00840A (enExample) | ||
| EA201692020A1 (ru) | Пролекарственные средства янтарной кислоты для применения в лечении лактоацидоза или индуцируемого лекарственными средствами побочного действия вследствие связанных с комплексом i нарушений окислительного фосфорилирования в митохондриях | |
| PL3373922T3 (pl) | Kompozycje i sposoby do stosowania do leczenia homocystynurii | |
| PH12017501897A1 (en) | 2-thiopyrimidinones | |
| MA40642A (fr) | Nouveaux dérivés peptidiques et leurs utilisations | |
| PH12018501166B1 (en) | Concentrated gibberellin solution formulations | |
| IN2014MU00205A (enExample) |